Centene Corporation
NYSE:CNCMedical - Healthcare Plans
+$0.67 today
- Market cap
- $31.58B
- Beta
- 1.09
- P/E (TTM)
- -4.7
- EPS (TTM)
- -$13.09
Volume 7.01M
Average 6.16M
Financial health
Centene Corporation financial health
Start with the overall verdict and the rule-based risk checks for CNC, then work through liquidity, debt, balance-sheet quality, and claims on cash.
Financial health snapshot
Debt service and balance sheet cushion look healthy, even if some working-capital ratios deserve context.
Cash & Investments
$43.36B
Debt Cushion
$27.25B
Current Ratio
1.1x
Interest Coverage
9.0x
Risk checks
2 of 11 checks flagged
Interest coverage
-8.3×
Passes when: Operating income is at least 1.5 times interest expense.
Tangible equity base
66.7%
Passes when: Goodwill and intangibles are below 50% of equity.
Positive equity
Positive
Passes when: Shareholders’ equity is above zero.
Short-term liquidity
1.1×
Passes when: Current assets are at least 1 times current liabilities.
Near-term debt coverage
360.8×
Passes when: Cash and short-term investments cover debt due within 12 months.
Manageable net debt
Net cash
Passes when: Net debt is below 3 times EBITDA.
Debt repayment from cash flow
1.8 yr
Passes when: Free cash flow could repay all debt within 5 years.
Debt growth versus revenue growth
-4.2% vs. 10.5%
Passes when: Over three years, debt growth is no more than 5 percentage points above revenue growth.
Altman Z-score trend
2.76 → 2.78
Passes when: The Z-score is stable or rising, or stays above 2.99.
Stock-based compensation
1.8%
Passes when: Stock-based compensation is no more than 20% of operating cash flow.
Share dilution
-3.2% per year
Passes when: Diluted share count grows no more than 2% per year.
Financial strength scores
How strong are the fundamentals over time?
Piotroski tests profitability, balance-sheet direction, and efficiency; Altman estimates bankruptcy risk. Compare the current scores with their fiscal-year history.
Financial strength scores
Piotroski F-Score and Altman Z-Score from the latest reported financials
Piotroski F-Score
Strong8 / 9
Nine pass/fail tests of profitability, balance-sheet strength, and efficiency. 8–9 is strong, 0–3 is weak.
Altman Z-Score
Safe zone3.35
Bankruptcy-risk model. Above 2.99 is the safe zone, 1.81–2.99 the grey zone, and below 1.81 the distress zone.
Score history
Piotroski F-Score and Altman Z-Score recalculated from each fiscal year's statements and year-end market value.
| Score | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Piotroski F (0–9) | 4 | 6 | 5 | 5 | 5 | 5 | 7 | 7 | 5 | 6 |
| Altman Z | 2.72 | 3.23 | 2.95 | 2.90 | 2.42 | 2.43 | 2.67 | 2.60 | 2.76 | 2.78 |
Piotroski: 8–9 strong, 4–7 average, 0–3 weak. Altman: above 2.99 safe, 1.81–2.99 grey, below 1.81 distress. Our calculation can differ slightly from the provider's current scores above.
Liquidity
Can it meet short-term obligations?
Check whether cash and current assets cover what falls due within a year without depending on fresh financing.
Cash & Equivalents
$24.15B
Q2 2026
Quick Ratio
1.1x
Q2 2026
Current Ratio
1.1x
Q2 2026
Cash Ratio
0.6x
Q2 2026
Working capital
How quickly does cash come back?
Receivable, inventory, and payable days show how much cash the operating cycle ties up and whether that is changing.
Working capital and cash conversion
Annual days measures from year-end receivables, inventory, and payables against revenue and cost of revenue.
Working capital (Q2 2026)
$5.93B
Current assets − current liabilities
Days sales outstanding
34 d
-10 days vs. prior year
Days inventory outstanding
0 d
+0 days vs. prior year
Days payables outstanding
44 d
+11 days vs. prior year
Cash conversion cycle
-10 d
-22 days vs. prior year
Leverage
How much debt risk sits on the balance sheet?
Review total borrowings, debt relative to equity and assets, and whether operating profit covers interest costs.
Total Debt
$16.11B
Q2 2026
Debt/Equity
0.7x
Q2 2026
Debt/Assets
0.2x
Q2 2026
Interest Coverage
9.0x
Q2 2026
Debt service
Can cash flow carry the debt?
Measure debt against EBITDA and free cash flow, see how much is due within 12 months, and follow debt and cash over time.
Debt service capacity
Can operating cash flow carry the debt, and how much is due soon?
Net debt
Net cash: $10.95B
Total debt − cash − short-term investments
Net debt / EBITDA
Net cash
Above 3× is elevated
Free cash flow / debt
55.7%
Share of debt one year of FCF could repay
Years to repay debt
1.8 yr
Total debt ÷ free cash flow
Operating cash flow / current liabilities
0.2×
Above 1× funds a year of obligations
Interest coverage
-8.3×
Operating income ÷ interest expense
Debt maturity
Cash and short-term investments cover short-term debt 360.8×.
Balance sheet as of Q2 2026; cash flows TTM to Q2 2026.
Debt and cash over time
Fiscal-year-end borrowings against liquid assets; net debt below zero means net cash.
Balance sheet cushion
How much room is there if conditions weaken?
Extra cash and investments, and the balance of assets against liabilities, give the company room when trading gets harder.
Long-Term Investments
$16.30B
Q2 2026
Assets
$83.01B
Q2 2026
Liabilities
$60.35B
Q2 2026
Balance sheet quality
Who funds the assets, and how tangible is the equity?
Split the claims on assets between suppliers, lenders, customers, and shareholders, and see how much equity rests on goodwill and intangibles.
Balance sheet quality
Who funds the assets, and how much of the equity is tangible (Q2 2026).
Claims on $83.01B in assets
- Payables21.7%
- Short-term debt0.1%
- Long-term debt19.3%
- Deferred revenue0.9%
- Other liabilities30.8%
- Equity27.2%
Goodwill + intangibles
$15.04B
18.1% of total assets
Share of equity
66.7%
Above 50% leaves little tangible backing
Tangible equity
$7.52B
Equity left after writing off goodwill and intangibles
Deferred revenue
$706M
Customer prepayments: a liability settled by delivering service, not cash
Competitor health
How does Centene Corporation compare with peers?
Compare leverage, interest coverage, and liquidity ratios with similar companies.
Competitor Health
Peer financial health comparison
| Company | Market Cap | D/E | D/Assets | ND/EBITDA | Int. Cov. | Quick | Current | Cash |
|---|---|---|---|---|---|---|---|---|
UnitedHealth Group Incorporated UNH:NYSE | $365.09B | 0.83 | 0.25 | 2.34 | 4.74 | 0.79 | 0.79 | 0.21 |
CVS Health Corp. CVS:NYSE | $114.32B | 1.24 | 0.36 | 8.63 | 3.33 | 0.63 | 0.84 | 0.10 |
Elevance Health Inc. ELV:NYSE | $92.84B | 0.76 | 0.27 | 2.46 | 5.79 | 1.24 | 1.24 | 0.48 |
Cigna Corporation CI:NYSE | $78.26B | 0.75 | 0.20 | 2.02 | 6.61 | 0.72 | 0.85 | 0.14 |
Humana Inc. HUM:NYSE | $54.05B | 0.73 | 0.27 | 3.00 | 2.30 | 0.72 | 0.72 | 0.41 |
Molina Healthcare, Inc. MOH:NYSE | $10.94B | 0.97 | 0.25 | Net cash | 4.07 | 1.69 | 1.69 | 0.58 |
Oscar Health, Inc. OSCR:NYSE | $8.05B | 0.44 | 0.07 | 5.99 | — | 0.95 | 0.95 | 0.57 |
Alignment Healthcare, Inc. ALHC:NASDAQ | $1.54B | 1.89 | 0.32 | Net cash | 0.93 | 1.74 | 1.74 | 1.21 |
Questions
Financial health questions
Common questions about CNC's balance sheet, answered from the reported figures.
Is CNC's balance sheet healthy?
Centene Corporation (CNC) has a current ratio of 1.15, a quick read on short-term liquidity.
How leveraged is CNC?
Debt to equity is 0.71, which helps judge how much financing risk sits on the balance sheet.
Continue the stock analysis
Jump to another research area for this company.